These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18439851)
21. Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome. Machado NO; Chopra P JOP; 2009 Jul; 10(4):413-8. PubMed ID: 19581746 [TBL] [Abstract][Full Text] [Related]
22. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy. Russo P; O'Brien MF Urol Clin North Am; 2008 Nov; 35(4):679-86; viii. PubMed ID: 18992621 [TBL] [Abstract][Full Text] [Related]
23. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. Hellenthal NJ; Chamie K; Ramirez ML; deVere White RW J Urol; 2009 Mar; 181(3):1013-8; discussion 1018-9. PubMed ID: 19150554 [TBL] [Abstract][Full Text] [Related]
24. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma. Harshman LC; Srinivas S Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749 [TBL] [Abstract][Full Text] [Related]
31. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819 [TBL] [Abstract][Full Text] [Related]
32. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316 [TBL] [Abstract][Full Text] [Related]
34. Partial nephrectomy without hilar control or cooling: longitudinal data over 5 years. Corcoran AT; Hayn MH; Gibbons EP; Mori R; Hrebinko R; Davies BJ Can J Urol; 2009 Oct; 16(5):4820-5. PubMed ID: 19796457 [TBL] [Abstract][Full Text] [Related]
35. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy. Kwan KG; Kapoor A Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804 [TBL] [Abstract][Full Text] [Related]
36. Lenalidomide therapy for metastatic renal cell carcinoma. Amato RJ; Hernandez-McClain J; Saxena S; Khan M Am J Clin Oncol; 2008 Jun; 31(3):244-9. PubMed ID: 18525302 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma. Amato RJ; Malya R; Rawat A Am J Clin Oncol; 2008 Jun; 31(3):237-43. PubMed ID: 18525301 [TBL] [Abstract][Full Text] [Related]
38. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma. Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267 [TBL] [Abstract][Full Text] [Related]
39. EORTC-GU group expert opinion on metastatic renal cell cancer. de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861 [TBL] [Abstract][Full Text] [Related]
40. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]